Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiqi Fumai lyophilized injection added to standard therapy for acute heart failure
ChiCTR2000029117Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Oct 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of yiqi fumai in Acute Heart Failure (AHF) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: 90-day all-cause mortality, 90-day heart failure rehospitalization and 1 more. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
yiqi fumai
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on ChiCTR2000029117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029117.